SORANIX (SORAFENIB) 200MG TABLETS 30`S

KSh8,320.00

SKU: DP8305 Category:

INDICATIONS.

Hepatocellular carcinoma

Sorafenib Zentiva is indicated for the treatment of hepatocellular carcinoma

Renal cell carcinoma

Sorafenib Zentiva is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

DOSAGE.

The recommended dose of Sorafenib  in adults is 400 mg sorafenib (two tablets of 200 mg) twice daily (equivalent to a total daily dose of 800 mg).

Treatment should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.

The safety and efficacy of Sorafenib  in children and adolescents aged < 18 years have not yet been established.

ADVERSE EFFECTS.

Thrombocytopenia

Anemia

Diarrhea

Rash/desquamation

Fatigue

Abdominal pain

Hand-foot skin reaction

Weight loss

Anorexia

Alopecia

Nausea

Lymphopenia

Neutropenia

Hemorrhage

Hypertension

Vomiting

Constipation

Neuropathy

Dry skin

0